(Q33260630)

24 July 2017

title

Screening for modulators of aggregation with a microplate elongation assay (English)

1 reference

24 July 2017

Valerie Berthelier

1

1 reference

24 July 2017

Ronald Wetzel

series ordinal

2

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

24 July 2017

published in

Methods in Enzymology

1 reference

24 July 2017

volume

413

1 reference

24 July 2017

page(s)

313-325

1 reference

A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Impairment of the ubiquitin-proteasome system by protein aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

A microtiter plate assay for polyglutamine aggregate extension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Europium as a label in time-resolved immunofluorometric assays

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Altered transcription in yeast expressing expanded polyglutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Neurodegenerative disease: amyloid pores from pathogenic mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

New Class of Inhibitors of Amyloid-beta Fibril Formation. IMPLICATIONS FOR THE MECHANISM OF PATHOGENESIS IN ALZHEIMER'S DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Chemical genetic screening approaches to neurobiology

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

From Alzheimer to Huntington: why is a structural understanding so difficult?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

Structural properties of Abeta protofibrils stabilized by a small molecule.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913016-5

7 January 2021

10.1016/S0076-6879(06)13016-5

Identifiers

DOI

1 reference

24 July 2017

1 reference